Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide - PubMed (original) (raw)

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

L J Ignarro et al. Proc Natl Acad Sci U S A. 1987 Dec.

Abstract

The objective of this study was to determine whether nitric oxide (NO) is responsible for the vascular smooth muscle relaxation elicited by endothelium-derived relaxing factor (EDRF). EDRF is an unstable humoral substance released from artery and vein that mediates the action of endothelium-dependent vasodilators. NO is an unstable endothelium-independent vasodilator that is released from vasodilator drugs such as nitroprusside and glyceryl trinitrate. We have repeatedly observed that the actions of NO on vascular smooth muscle closely resemble those of EDRF. In the present study the vascular effects of EDRF released from perfused bovine intrapulmonary artery and vein were compared with the effects of NO delivered by superfusion over endothelium-denuded arterial and venous strips arranged in a cascade. EDRF was indistinguishable from NO in that both were labile (t1/2 = 3-5 sec), inactivated by pyrogallol or superoxide anion, stabilized by superoxide dismutase, and inhibited by oxyhemoglobin or potassium. Both EDRF and NO produced comparable increases in cyclic GMP accumulation in artery and vein, and this cyclic GMP accumulation was inhibited by pyrogallol, oxyhemoglobin, potassium, and methylene blue. EDRF was identified chemically as NO, or a labile nitroso species, by two procedures. First, like NO, EDRF released from freshly isolated aortic endothelial cells reacted with hemoglobin to yield nitrosylhemoglobin. Second, EDRF and NO each similarly promoted the diazotization of sulfanilic acid and yielded the same reaction product after coupling with N-(1-naphthyl)-ethylenediamine. Thus, EDRF released from artery and vein possesses identical biological and chemical properties as NO.

PubMed Disclaimer

Cited by

Nitric oxide and cancer: a review.
Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Choudhari SK, et al. World J Surg Oncol. 2013 May 30;11:118. doi: 10.1186/1477-7819-11-118. World J Surg Oncol. 2013. PMID: 23718886 Free PMC article. Review.
Endothelial Nitric Oxide Synthase-Deficient Mice: A Model of Spontaneous Cerebral Small-Vessel Disease.
Liao FF, Lin G, Chen X, Chen L, Zheng W, Raghow R, Zhou FM, Shih AY, Tan XL. Liao FF, et al. Am J Pathol. 2021 Nov;191(11):1932-1945. doi: 10.1016/j.ajpath.2021.02.022. Epub 2021 Mar 10. Am J Pathol. 2021. PMID: 33711310 Free PMC article. Review.
Nitric oxide in asthma physiopathology.
Prado CM, Martins MA, Tibério IF. Prado CM, et al. ISRN Allergy. 2011 Apr 19;2011:832560. doi: 10.5402/2011/832560. Print 2011. ISRN Allergy. 2011. PMID: 23724233 Free PMC article.
Glutathiyl radical as an intermediate in glutathione nitrosation.
Madrasi K, Joshi MS, Gadkari T, Kavallieratos K, Tsoukias NM. Madrasi K, et al. Free Radic Biol Med. 2012 Nov 15;53(10):1968-76. doi: 10.1016/j.freeradbiomed.2012.08.013. Epub 2012 Aug 22. Free Radic Biol Med. 2012. PMID: 22951977 Free PMC article.
Prospect of early vascular tone and satellite cell modulations on white striping muscle myopathy.
Ayansola H, Liao C, Dong Y, Yu X, Zhang B, Wang B. Ayansola H, et al. Poult Sci. 2021 Mar;100(3):100945. doi: 10.1016/j.psj.2020.12.042. Epub 2020 Dec 25. Poult Sci. 2021. PMID: 33652536 Free PMC article. Review.

References

1. J Pharmacol Exp Ther. 1984 Mar;228(3):682-90 - PubMed
1. J Pharmacol Exp Ther. 1984 Jan;228(1):33-42 - PubMed
1. J Biol Chem. 1984 May 10;259(9):5923-31 - PubMed
1. Am J Physiol. 1984 Jun;246(6 Pt 2):H776-83 - PubMed
1. J Pharmacol Exp Ther. 1985 Mar;232(3):708-16 - PubMed

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide - PubMed (original) (raw)